Anti-Human IL28A/IFNL2 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22001; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-Human IL28A/IFNL2 Polyclonal Antibody: Unlocking the Power of Interferon Lambda Signaling
The Anti-Human IL28A/IFNL2 Polyclonal Antibody is a powerful tool for researchers in the field of biotechnology. This highly specific antibody targets the interferon lambda (IFNL) signaling pathway, providing valuable insights into the role of IFNL in various biological processes.
IFNLs are a group of cytokines that play a crucial role in the innate immune response. They are primarily produced by immune cells in response to viral infections and have been shown to have antiviral and anti-tumor properties. The Anti-Human IL28A/IFNL2 Polyclonal Antibody specifically targets IL28A and IFNL2, which are two important members of the IFNL family.
This antibody is a valuable tool for studying the role of IFNL in various biological processes. It can be used in both in vitro and in vivo experiments to investigate the function of IFNL in immune responses, viral infections, and cancer. Additionally, this antibody can be used in diagnostic assays to detect the presence of IL28A and IFNL2 in biological samples.
– Investigating the role of IFNL in viral infections: The Anti-Human IL28A/IFNL2 Polyclonal Antibody can be used to study the expression and function of IFNL in viral infections, such as hepatitis C and influenza. This can provide valuable insights into the mechanisms of viral pathogenesis and aid in the development of new antiviral therapies.
– Examining the role of IFNL in cancer: Studies have shown that IFNL has anti-tumor properties and can inhibit the growth of certain types of cancer cells. The Anti-Human IL28A/IFNL2 Polyclonal Antibody can be used to investigate the role of IFNL in cancer development and progression, potentially leading to the development of new cancer treatments.
– Developing diagnostic assays: The high specificity of this antibody makes it an ideal tool for developing diagnostic assays to detect the presence of IL28A and IFNL2 in biological samples. This can aid in the early detection and treatment of diseases related to IFNL dysregulation.
With its ability to specifically target IL28A and IFNL2, the Anti-Human IL28A/IFNL2 Polyclonal Antibody offers researchers a powerful tool to unlock the potential of IFNL signaling in various biological processes. Its applications in viral infections, cancer research, and diagnostic assays make it a valuable addition to any biotech laboratory. Order now and discover the power of IFNL in your research.
ProteoGenix catalogue number ARO-A22001. For research use only.
Target: IL28A/IFNL2; Clonality: Polyclonal Antibody; Reactivity: Human; Applications: IHC, ELISA, WB.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
